{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T14:12:02Z","timestamp":1790950322737,"version":"4.1.0"},"reference-count":115,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:00:00Z","timestamp":1758585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:00:00Z","timestamp":1758585600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB TRR219 \u2013 Project-ID 322900939"],"award-info":[{"award-number":["SFB TRR219 \u2013 Project-ID 322900939"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB1123-A1"],"award-info":[{"award-number":["SFB1123-A1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["310030_197655"],"award-info":[{"award-number":["310030_197655"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016021","name":"Corona-Stiftung","doi-asserted-by":"publisher","award":["S199\/10084\/2021"],"award-info":[{"award-number":["S199\/10084\/2021"]}],"id":[{"id":"10.13039\/100016021","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004784","name":"Novartis Stiftung\u00a0f\u00fcr\u00a0Medizinisch-Biologische Forschung","doi-asserted-by":"publisher","award":["22B148"],"award-info":[{"award-number":["22B148"]}],"id":[{"id":"10.13039\/501100004784","id-type":"DOI","asserted-by":"publisher"}]},{"name":"University of Bern"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Basic Res Cardiol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cardiovascular diseases (CVD) include a wide range of disorders affecting the heart and blood vessels, many of which are associated with atherosclerosis. Atherosclerosis is the main underlying cause of CVDs and represents a chronic inflammatory disease of the large arteries involving the build-up of plaques within the arterial wall. B cells play a dual role in CVD, particularly in the context of atherosclerosis, by producing antibodies and secreting cytokines that modulate inflammation. Depending on their subtype (B1 vs. B2 cells) and the specific context, B cells can have both protective and harmful effects on the cardiovascular system. B1 cells, which arise predominantly during fetal development, are found in body cavities, such as the perivascular adipose tissue (PVAT) and peritoneum. Guided by CXCL13 and CCR6, they migrate to sites, where they produce IgM and IgG3, contributing to immune regulation and pathogen defense. In contrast, B2 cells\u2014central players in adaptive immunity\u2014originate in the bone marrow and mature in secondary lymphoid organs. Within this subset, marginal-zone (MZ) B cells provide rapid, low-affinity IgM responses to blood-borne antigens, while follicular (FO) B cells mediate high-affinity, T-cell-dependent antibody production. For all of the latter chemokine-guided migration is essential for B-cell function, from immune surveillance to antibody secretion. Receptors such as CXCR4, CXCR5, and ACKR3 not only direct B-cell trafficking but also influence their phenotype in cardiovascular disease. Understanding how these chemokine\u2013receptor interactions shape B-cell-mediated immunity in CVD may allow for developing targeted therapies for atherosclerosis, myocardial infarction, and stroke.<\/jats:p>","DOI":"10.1007\/s00395-025-01140-x","type":"journal-article","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T13:25:14Z","timestamp":1758633914000},"page":"1075-1090","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Chemokine\u2013receptor-guided B-cell immunity in cardiovascular disease"],"prefix":"10.1007","volume":"120","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-4058-2010","authenticated-orcid":false,"given":"Anais","family":"Yerly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emiel P. C.","family":"van der Vorst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Schindewolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Drosos","family":"Kotelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi","family":"Noels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"D\u00f6ring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,23]]},"reference":[{"key":"1140_CR1","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.134700","volume":"5","author":"L Adamo","year":"2020","unstructured":"Adamo L, Rocha-Resende C, Lin C-Y, Evans S, Williams J, Dun H, Li W, Mpoy C, Andhey PS, Rogers BE, Lavine K, Kreisel D, Artyomov M, Randolph GJ, Mann DL (2020) Myocardial B cells are a subset of circulating lymphocytes with delayed transit through the heart. JCI Insight 5:e134700. https:\/\/doi.org\/10.1172\/jci.insight.134700","journal-title":"JCI Insight"},{"key":"1140_CR2","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1084\/jem.20100155","volume":"207","author":"H Ait-Oufella","year":"2010","unstructured":"Ait-Oufella H, Herbin O, Bouaziz J-D, Binder CJ, Uyttenhove C, Laurans L, Taleb S, Van Vr\u00e9 E, Esposito B, Vilar J, Sirvent J, Van Snick J, Tedgui A, Tedder TF, Mallat Z (2010) B cell depletion reduces the development of atherosclerosis in mice. J Exp Med 207:1579\u20131587. https:\/\/doi.org\/10.1084\/jem.20100155","journal-title":"J Exp Med"},{"key":"1140_CR3","doi-asserted-by":"publisher","first-page":"4497","DOI":"10.1096\/fj.15-273904","volume":"29","author":"S Alampour-Rajabi","year":"2015","unstructured":"Alampour-Rajabi S, El Bounkari O, Rot A, M\u00fcller-Newen G, Bachelerie F, Gawaz M, Weber C, Schober A, Bernhagen J (2015) MIF interacts with CXCR7 to promote receptor internalization, ERK1\/2 and ZAP-70 signaling, and lymphocyte chemotaxis. FASEB J 29:4497\u20134511. https:\/\/doi.org\/10.1096\/fj.15-273904","journal-title":"FASEB J"},{"key":"1140_CR4","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.immuni.2004.06.019","volume":"21","author":"KR Alugupalli","year":"2004","unstructured":"Alugupalli KR, Leong JM, Woodland RT, Muramatsu M, Honjo T, Gerstein RM (2004) B1b lymphocytes confer T cell-independent long-lasting immunity. Immunity 21:379\u2013390. https:\/\/doi.org\/10.1016\/j.immuni.2004.06.019","journal-title":"Immunity"},{"key":"1140_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-025-01165-8","author":"I Andreadou","year":"2025","unstructured":"Andreadou I, Ghigo A, Nikolaou PE, Swirski FK, Thackeray JT, Heusch G, Vilahur G (2025) Immunometabolism in heart failure. Nat Rev Cardiol. https:\/\/doi.org\/10.1038\/s41569-025-01165-8","journal-title":"Nat Rev Cardiol"},{"key":"1140_CR6","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S1074-7613(01)00257-6","volume":"16","author":"KM Ansel","year":"2002","unstructured":"Ansel KM, Harris RBS, Cyster JG (2002) CXCL13 is required for B1 cell homing, natural antibody production, and body cavity immunity. Immunity 16:67\u201376. https:\/\/doi.org\/10.1016\/S1074-7613(01)00257-6","journal-title":"Immunity"},{"key":"1140_CR7","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1182\/blood.2023022658","volume":"144","author":"R Badolato","year":"2024","unstructured":"Badolato R, Alsina L, Azar A, Bertrand Y, Bolyard AA, Dale D, Dey\u00e0-Mart\u00ednez \u00c0, Dickerson KE, Ezra N, Hasle H, Kang HJ, Kiani-Alikhan S, Kuijpers TW, Kulagin A, Langguth D, Levin C, Neth O, Olbrich P, Peake J, Rodina Y, Rutten CE, Shcherbina A, Tarrant TK, Vossen MG, Wysocki CA, Belschner A, Bridger GJ, Chen K, Dubuc S, Hu Y, Jiang H, Li S, MacLeod R, Stewart M, Taveras AG, Yan T, Donadieu J (2024) A phase 3 randomized trial of mavorixafor, a CXCR4 antagonist, for WHIM syndrome. Blood 144:35\u201345. https:\/\/doi.org\/10.1182\/blood.2023022658","journal-title":"Blood"},{"key":"1140_CR8","doi-asserted-by":"publisher","first-page":"13700","DOI":"10.1073\/pnas.1107172108","volume":"108","author":"CL Barber","year":"2011","unstructured":"Barber CL, Montecino-Rodriguez E, Dorshkind K (2011) Reduced production of B-1\u2013specified common lymphoid progenitors results in diminished potential of adult marrow to generate B-1 cells. Proc Natl Acad Sci U S A 108:13700\u201313704. https:\/\/doi.org\/10.1073\/pnas.1107172108","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1140_CR9","doi-asserted-by":"publisher","first-page":"3040","DOI":"10.1002\/eji.200636483","volume":"37","author":"TA Barr","year":"2007","unstructured":"Barr TA, Brown S, Ryan G, Zhao J, Gray D (2007) TLR-mediated stimulation of APC: distinct cytokine responses of B cells and dendritic cells. Eur J Immunol 37:3040\u20133053. https:\/\/doi.org\/10.1002\/eji.200636483","journal-title":"Eur J Immunol"},{"key":"1140_CR10","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.jacbts.2024.09.011","volume":"10","author":"KC Bilchick","year":"2025","unstructured":"Bilchick KC, Cochran JD, McSkimming C, Kothari H, Ma Z, Bivona DJ, Bekiranov S, McNamara C (2025) CXC-chemokine-receptor-type-5 expression on circulating naive B cells predicts improvement after cardiac resynchronization therapy. JACC: Basic Transl Sci 10:221\u2013223. https:\/\/doi.org\/10.1016\/j.jacbts.2024.09.011","journal-title":"JACC: Basic Transl Sci"},{"key":"1140_CR11","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s10875-010-9396-3","volume":"30","author":"CJ Binder","year":"2010","unstructured":"Binder CJ (2010) Natural IgM antibodies against oxidation-specific epitopes. J Clin Immunol 30:56\u201360. https:\/\/doi.org\/10.1007\/s10875-010-9396-3","journal-title":"J Clin Immunol"},{"key":"1140_CR12","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s11011-013-9474-3","volume":"29","author":"S Bodhankar","year":"2014","unstructured":"Bodhankar S, Chen Y, Vandenbark AA, Murphy SJ, Offner H (2014) Treatment of experimental stroke with IL-10-producing B-cells reduces infarct size and peripheral and CNS inflammation in wild-type B-cell-sufficient mice. Metab Brain Dis 29:59\u201373. https:\/\/doi.org\/10.1007\/s11011-013-9474-3","journal-title":"Metab Brain Dis"},{"key":"1140_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00224","author":"R Bonecchi","year":"2016","unstructured":"Bonecchi R, Graham GJ (2016) Atypical chemokine receptors and their roles in the resolution of the inflammatory response. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2016.00224","journal-title":"Front Immunol"},{"key":"1140_CR14","doi-asserted-by":"publisher","first-page":"1297596","DOI":"10.3389\/fphar.2023.1297596","volume":"14","author":"R Bonnavion","year":"2023","unstructured":"Bonnavion R, Liu S, Kawase H, Roquid KA, Offermanns S (2023) Large chemokine binding spectrum of human and mouse atypical chemokine receptor GPR182 (ACKR5). Front Pharmacol 14:1297596. https:\/\/doi.org\/10.3389\/fphar.2023.1297596","journal-title":"Front Pharmacol"},{"key":"1140_CR15","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1038\/29788","volume":"394","author":"L Boring","year":"1998","unstructured":"Boring L, Gosling J, Cleary M, Charo IF (1998) Decreased lesion formation in CCR2\u2212\/\u2212 mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 394:894\u2013897. https:\/\/doi.org\/10.1038\/29788","journal-title":"Nature"},{"key":"1140_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-00104-z","volume":"7","author":"I Bot","year":"2017","unstructured":"Bot I, Ortiz Zacar\u00edas NV, De Witte WEA, De Vries H, Van Santbrink PJ, Van Der Velden D, Kr\u00f6ner MJ, Van Der Berg D-J, Stamos D, De Lange ECM, Kuiper J, Ijzerman AP, Heitman LH (2017) A novel CCR2 antagonist inhibits atherogenesis in apoE deficient mice by achieving high receptor occupancy. Sci Rep 7:52. https:\/\/doi.org\/10.1038\/s41598-017-00104-z","journal-title":"Sci Rep"},{"key":"1140_CR17","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1182\/blood-2005-08-3182","volume":"107","author":"JA Burger","year":"2006","unstructured":"Burger JA, Kipps TJ (2006) CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment. Blood 107:1761\u20131767. https:\/\/doi.org\/10.1182\/blood-2005-08-3182","journal-title":"Blood"},{"key":"1140_CR18","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20203413","volume":"41","author":"ACA Casarotti","year":"2021","unstructured":"Casarotti ACA, Teixeira D, Longo-Maugeri IM, Ishimura ME, Coste MER, Bianco HT, Moreira FT, Bacchin AF, Izar MC, Gon\u00e7alves I, Caixeta A, Szarf G, Pinto IM, Fonseca FA (2021) Role of B lymphocytes in the infarcted mass in patients with acute myocardial infarction. Biosci Rep 41:BSR20203413. https:\/\/doi.org\/10.1042\/BSR20203413","journal-title":"Biosci Rep"},{"key":"1140_CR19","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1161\/CIRCULATIONAHA.118.038534","volume":"139","author":"M Centa","year":"2019","unstructured":"Centa M, Jin H, Hofste L, Hellberg S, Busch A, Baumgartner R, Verzaal NJ, Lind Enoksson S, Perisic Matic L, Boddul SV, Atzler D, Li DY, Sun C, Hansson GK, Ketelhuth DFJ, Hedin U, Wermeling F, Lutgens E, Binder CJ, Maegdesfessel L, Malin SG (2019) Germinal center-derived antibodies promote atherosclerosis plaque size and stability. Circulation 139:2466\u20132482. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.038534","journal-title":"Circulation"},{"key":"1140_CR20","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/nri3383","volume":"13","author":"A Cerutti","year":"2013","unstructured":"Cerutti A, Cols M, Puga I (2013) Marginal zone B cells: virtues of innate-like antibody-producing lymphocytes. Nat Rev Immunol 13:118\u2013132. https:\/\/doi.org\/10.1038\/nri3383","journal-title":"Nat Rev Immunol"},{"key":"1140_CR21","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1002\/eji.201141890","volume":"42","author":"YS Choi","year":"2012","unstructured":"Choi YS, Dieter JA, Rothaeusler K, Luo Z, Baumgarth N (2012) B-1 cells in the bone marrow are a significant source of natural IgM. Eur J Immunol 42:120\u2013129. https:\/\/doi.org\/10.1002\/eji.201141890","journal-title":"Eur J Immunol"},{"key":"1140_CR22","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/ni1542","volume":"9","author":"G Cinamon","year":"2008","unstructured":"Cinamon G, Zachariah MA, Lam OM, Foss FW, Cyster JG (2008) Follicular shuttling of marginal zone B cells facilitates antigen transport. Nat Immunol 9:54\u201362. https:\/\/doi.org\/10.1038\/ni1542","journal-title":"Nat Immunol"},{"key":"1140_CR23","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1161\/CIRCULATIONAHA.113.001278","volume":"127","author":"S Cipriani","year":"2013","unstructured":"Cipriani S, Francisci D, Mencarelli A, Renga B, Schiaroli E, D\u2019Amore C, Baldelli F, Fiorucci S (2013) Efficacy of the CCR5 antagonist maraviroc in reducing early, ritonavir-induced atherogenesis and advanced plaque progression in mice. Circulation 127:2114\u20132124. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.113.001278","journal-title":"Circulation"},{"key":"1140_CR24","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1084\/jem.20170771","volume":"215","author":"AJ Clarke","year":"2018","unstructured":"Clarke AJ, Riffelmacher T, Braas D, Cornall RJ, Simon AK (2018) B1a B cells require autophagy for metabolic homeostasis and self-renewal. J Exp Med 215:399\u2013413. https:\/\/doi.org\/10.1084\/jem.20170771","journal-title":"J Exp Med"},{"key":"1140_CR25","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s13075-024-03337-2","volume":"26","author":"S Cohen","year":"2024","unstructured":"Cohen S, Beebe JS, Chindalore V, Guan S, Hassan-Zahraee M, Saxena M, Xi L, Hyde C, Koride S, Levin R, Lubaczewski S, Salganik M, Sloan A, Stevens E, Peeva E, Vincent MS, Martin DA, Chu M (2024) A phase 1, randomized, double-blind, placebo-controlled, single- and multiple-dose escalation study to evaluate the safety and pharmacokinetics\/pharmacodynamics of PF-06835375, a C-X-C chemokine receptor type 5 directed antibody, in patients with systemic lupus erythematosus or rheumatoid arthritis. Arthritis Res Ther 26:117. https:\/\/doi.org\/10.1186\/s13075-024-03337-2","journal-title":"Arthritis Res Ther"},{"key":"1140_CR26","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/nri3804","volume":"15","author":"NS De Silva","year":"2015","unstructured":"De Silva NS, Klein U (2015) Dynamics of B cells in germinal centres. Nat Rev Immunol 15:137\u2013148. https:\/\/doi.org\/10.1038\/nri3804","journal-title":"Nat Rev Immunol"},{"key":"1140_CR27","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/S2213-8587(15)00261-2","volume":"3","author":"D De Zeeuw","year":"2015","unstructured":"De Zeeuw D, Bekker P, Henkel E, Hasslacher C, Gouni-Berthold I, Mehling H, Potarca A, Tesar V, Heerspink HJL, Schall TJ (2015) The effect of CCR2 inhibitor CCX140-B on residual albuminuria in patients with type 2 diabetes and nephropathy: a randomised trial. Lancet Diabetes Endocrinol 3:687\u2013696. https:\/\/doi.org\/10.1016\/S2213-8587(15)00261-2","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1140_CR28","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1161\/CIRCRESAHA.119.316142","volume":"126","author":"Y D\u00f6ring","year":"2020","unstructured":"D\u00f6ring Y, Jansen Y, Cimen I, Aslani M, Gencer S, Peters LJF, Duchene J, Weber C, Van Der Vorst EPC (2020) B-cell\u2013specific CXCR4 protects against atherosclerosis development and increases plasma IgM levels. Circ Res 126:787\u2013788. https:\/\/doi.org\/10.1161\/CIRCRESAHA.119.316142","journal-title":"Circ Res"},{"key":"1140_CR29","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1161\/CIRCULATIONAHA.118.037953","volume":"139","author":"Y D\u00f6ring","year":"2019","unstructured":"D\u00f6ring Y, Van Der Vorst EPC, Duchene J, Jansen Y, Gencer S, Bidzhekov K, Atzler D, Santovito D, Rader DJ, Saleheen D, Weber C (2019) Cxcl12 derived from endothelial cells promotes atherosclerosis to drive coronary artery disease. Circulation 139:1338\u20131340. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.037953","journal-title":"Circulation"},{"key":"1140_CR30","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1038\/s41569-024-01023-z","volume":"21","author":"Y D\u00f6ring","year":"2024","unstructured":"D\u00f6ring Y, Van Der Vorst EPC, Weber C (2024) Targeting immune cell recruitment in atherosclerosis. Nat Rev Cardiol 21:824\u2013840. https:\/\/doi.org\/10.1038\/s41569-024-01023-z","journal-title":"Nat Rev Cardiol"},{"key":"1140_CR31","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/s44161-023-00413-9","volume":"3","author":"Y D\u00f6ring","year":"2024","unstructured":"D\u00f6ring Y, Van Der Vorst EPC, Yan Y, Neideck C, Blanchet X, Jansen Y, Kemmerich M, Bayasgalan S, Peters LJF, Hristov M, Bidzhekov K, Yin C, Zhang X, Leberzammer J, Li Y, Park I, Kral M, Nitz K, Parma L, Gencer S, Habenicht AJR, Faussner A, Teupser D, Monaco C, Holdt L, Megens RTA, Atzler D, Santovito D, Von Hundelshausen P, Weber C (2024) Identification of a non-canonical chemokine-receptor pathway suppressing regulatory T cells to drive atherosclerosis. Nat Cardiovasc Res 3:221\u2013242. https:\/\/doi.org\/10.1038\/s44161-023-00413-9","journal-title":"Nat Cardiovasc Res"},{"key":"1140_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.906586","volume":"13","author":"V Duval","year":"2022","unstructured":"Duval V, Alayrac P, Silvestre J-S, Levoye A (2022) Emerging roles of the atypical chemokine receptor 3 (ACKR3) in cardiovascular diseases. Front Endocrinol 13:906586. https:\/\/doi.org\/10.3389\/fendo.2022.906586","journal-title":"Front Endocrinol"},{"key":"1140_CR33","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1002\/jnr.20176","volume":"77","author":"AE Edling","year":"2004","unstructured":"Edling AE, Nanavati T, Johnson JM, Tuohy VK (2004) Human and murine lymphocyte neurotrophin expression is confined to B cells. J Neurosci Res 77:709\u2013717. https:\/\/doi.org\/10.1002\/jnr.20176","journal-title":"J Neurosci Res"},{"key":"1140_CR34","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/j.1600-065X.2009.00782.x","volume":"229","author":"R Elgueta","year":"2009","unstructured":"Elgueta R, Benson MJ, De Vries VC, Wasiuk A, Guo Y, Noelle RJ (2009) Molecular mechanism and function of CD40\/CD40L engagement in the immune system. Immunol Rev 229:152\u2013172. https:\/\/doi.org\/10.1111\/j.1600-065X.2009.00782.x","journal-title":"Immunol Rev"},{"key":"1140_CR35","doi-asserted-by":"publisher","first-page":"5773","DOI":"10.1073\/pnas.0811632106","volume":"106","author":"BL Esplin","year":"2009","unstructured":"Esplin BL, Welner RS, Zhang Q, Borghesi LA, Kincade PW (2009) A differentiation pathway for B1 cells in adult bone marrow. Proc Natl Acad Sci USA 106:5773\u20135778. https:\/\/doi.org\/10.1073\/pnas.0811632106","journal-title":"Proc Natl Acad Sci USA"},{"key":"1140_CR36","doi-asserted-by":"publisher","first-page":"3027","DOI":"10.4049\/jimmunol.181.5.3027","volume":"181","author":"A-L Fauchais","year":"2008","unstructured":"Fauchais A-L, Lallou\u00e9 F, Lise M-C, Boumediene A, Preud\u2019homme J-L, Vidal E, Jauberteau M-O (2008) Role of endogenous brain-derived neurotrophic factor and sortilin in B cell survival. J Immunol 181:3027\u20133038. https:\/\/doi.org\/10.4049\/jimmunol.181.5.3027","journal-title":"J Immunol"},{"key":"1140_CR37","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1111\/apt.13398","volume":"42","author":"BG Feagan","year":"2015","unstructured":"Feagan BG, Sandborn WJ, D\u2019Haens G, Lee SD, Allez M, Fedorak RN, Seidler U, Vermeire S, Lawrance IC, Maroney AC, Jurgensen CH, Heath A, Chang DJ (2015) Randomised clinical trial: vercirnon, an oral CCR9 antagonist, vs. placebo as induction therapy in active Crohn\u2019s disease. Aliment Pharmacol Ther 42:1170\u20131181. https:\/\/doi.org\/10.1111\/apt.13398","journal-title":"Aliment Pharmacol Ther"},{"key":"1140_CR38","doi-asserted-by":"publisher","first-page":"1084460","DOI":"10.3389\/fimmu.2022.1084460","volume":"13","author":"Q Feng","year":"2023","unstructured":"Feng Q, Li Q, Zhou H, Sun L, Lin C, Jin Y, Wang D, Guo G (2023) The role of major immune cells in myocardial infarction. Front Immunol 13:1084460. https:\/\/doi.org\/10.3389\/fimmu.2022.1084460","journal-title":"Front Immunol"},{"key":"1140_CR39","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofz112","volume-title":"Open forum infectious diseases","author":"D Francisci","year":"2019","unstructured":"Francisci D, Pirro M, Schiaroli E, Mannarino MR, Cipriani S, Bianconi V, Alunno A, Bagaglia F, Bistoni O, Falcinelli E, Bury L, Gerli R, Mannarino E, De Caterina R, Baldelli F (2019) Maraviroc intensification modulates atherosclerotic progression in HIV-suppressed patients at high cardiovascular risk. a randomized, crossover pilot study. Open forum infectious diseases. Oxford University Press US. https:\/\/doi.org\/10.1093\/ofid\/ofz112"},{"key":"1140_CR40","doi-asserted-by":"publisher","first-page":"153","DOI":"10.2174\/1573403X14666180222102312","volume":"14","author":"S Francula-Zaninovic","year":"2018","unstructured":"Francula-Zaninovic S, Nola IA (2018) Management of measurable variable cardiovascular disease\u2019 risk factors. CCR 14:153\u2013163. https:\/\/doi.org\/10.2174\/1573403X14666180222102312","journal-title":"CCR"},{"key":"1140_CR41","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/1741-7015-11-117","volume":"11","author":"J Frosteg\u00e5rd","year":"2013","unstructured":"Frosteg\u00e5rd J (2013) Immunity, atherosclerosis and cardiovascular disease. BMC Med 11:117. https:\/\/doi.org\/10.1186\/1741-7015-11-117","journal-title":"BMC Med"},{"key":"1140_CR42","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.cca.2019.05.022","volume":"495","author":"J-H Gao","year":"2019","unstructured":"Gao J-H, Yu X-H, Tang C-K (2019) CXC chemokine ligand 12 (CXCL12) in atherosclerosis: an underlying therapeutic target. Clin Chim Acta 495:538\u2013544. https:\/\/doi.org\/10.1016\/j.cca.2019.05.022","journal-title":"Clin Chim Acta"},{"key":"1140_CR43","doi-asserted-by":"publisher","first-page":"226","DOI":"10.3390\/cells10020226","volume":"10","author":"S Gencer","year":"2021","unstructured":"Gencer S, Evans BR, Van Der Vorst EPC, D\u00f6ring Y, Weber C (2021) Inflammatory chemokines in atherosclerosis. Cells 10:226. https:\/\/doi.org\/10.3390\/cells10020226","journal-title":"Cells"},{"key":"1140_CR44","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1055\/s-0038-1676988","volume":"119","author":"S Gencer","year":"2019","unstructured":"Gencer S, Van Der Vorst E, Aslani M, Weber C, D\u00f6ring Y, Duchene J (2019) Atypical chemokine receptors in cardiovascular disease. Thromb Haemost 119:534\u2013541. https:\/\/doi.org\/10.1055\/s-0038-1676988","journal-title":"Thromb Haemost"},{"key":"1140_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-025-01456-2","volume":"17","author":"MK Georgakis","year":"2025","unstructured":"Georgakis MK, Malik R, Bounkari OE, Hasbani NR, Li J, Huffman JE, Shakt G, Tack RWP, Kimball TN, Asare Y, Morrison AC, Tsao NL, Judy R, Mitchell BD, Xu H, Montasser ME, Do R, Kenny EE, Loos RJF, Terry JG, Carr JJ, Bis JC, Psaty BM, Longstreth WT, Young KA, Lutz SM, Cho MH, Broome J, Khan AT, Wang FF, Heard-Costa N, Seshadri S, Vasan RS, Palmer ND, Freedman BI, Bowden DW, Yanek LR, Kral BG, Becker LC, Peyser PA, Bielak LF, Ammous F, Carson AP, Hall ME, Raffield LM, Rich SS, Post WS, Tracy RP, Taylor KD, Guo X, Mahaney MC, Curran JE, Blangero J, Clarke SL, Haessler JW, Hu Y, Assimes TL, Kooperberg C, Bernhagen J, Anderson CD, Damrauer SM, Zand R, Rotter JI, De Vries PS, Dichgans M (2025) Rare damaging CCR2 variants are associated with lower lifetime cardiovascular risk. Genome Med 17:27. https:\/\/doi.org\/10.1186\/s13073-025-01456-2","journal-title":"Genome Med"},{"key":"1140_CR46","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s00395-023-01023-z","volume":"119","author":"I Gianopoulos","year":"2024","unstructured":"Gianopoulos I, Daskalopoulou SS (2024) Macrophage profiling in atherosclerosis: understanding the unstable plaque. Basic Res Cardiol 119:35\u201356. https:\/\/doi.org\/10.1007\/s00395-023-01023-z","journal-title":"Basic Res Cardiol"},{"key":"1140_CR47","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.amjcard.2010.11.005","volume":"107","author":"J Gilbert","year":"2011","unstructured":"Gilbert J, Lekstrom-Himes J, Donaldson D, Lee Y, Hu M, Xu J, Wyant T, Davidson M (2011) Effect of CC chemokine receptor 2 CCR2 blockade on serum C-reactive protein in individuals at atherosclerotic risk and with a single nucleotide polymorphism of the monocyte chemoattractant protein-1 promoter region. Am J Cardiol 107:906\u2013911. https:\/\/doi.org\/10.1016\/j.amjcard.2010.11.005","journal-title":"Am J Cardiol"},{"key":"1140_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-017-0322-3","volume":"24","author":"A Gombozhapova","year":"2017","unstructured":"Gombozhapova A, Rogovskaya Y, Shurupov V, Rebenkova M, Kzhyshkowska J, Popov SV, Karpov RS, Ryabov V (2017) Macrophage activation and polarization in post-infarction cardiac remodeling. J Biomed Sci 24:13. https:\/\/doi.org\/10.1186\/s12929-017-0322-3","journal-title":"J Biomed Sci"},{"key":"1140_CR49","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1146\/annurev-immunol-032713-120145","volume":"32","author":"JW Griffith","year":"2014","unstructured":"Griffith JW, Sokol CL, Luster AD (2014) Chemokines and chemokine receptors: positioning cells for host defense and immunity. Annu Rev Immunol 32:659\u2013702. https:\/\/doi.org\/10.1146\/annurev-immunol-032713-120145","journal-title":"Annu Rev Immunol"},{"key":"1140_CR50","doi-asserted-by":"publisher","first-page":"5413","DOI":"10.1182\/blood-2010-11-317115","volume":"117","author":"CAH Hansell","year":"2011","unstructured":"Hansell CAH, Schiering C, Kinstrie R, Ford L, Bordon Y, McInnes IB, Goodyear CS, Nibbs RJB (2011) Universal expression and dual function of the atypical chemokine receptor D6 on innate-like B cells in mice. Blood 117:5413\u20135424. https:\/\/doi.org\/10.1182\/blood-2010-11-317115","journal-title":"Blood"},{"issue":"1","key":"1140_CR51","doi-asserted-by":"publisher","first-page":"2","DOI":"10.21542\/gcsp.2018.2","volume":"2018","author":"M Hassan","year":"2018","unstructured":"Hassan M (2018) CANTOS: a breakthrough that proves the inflammatory hypothesis of atherosclerosis. Global Cardiol Sci Pract 2018(1):2. https:\/\/doi.org\/10.21542\/gcsp.2018.2","journal-title":"Global Cardiol Sci Pract"},{"key":"1140_CR52","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvab181","author":"M Heinrichs","year":"2021","unstructured":"Heinrichs M, Ashour D, Siegel J, B\u00fcchner L, Wedekind G, Heinze KG, Arampatzi P, Saliba A-E, Cochain C, Hofmann U, Frantz S, Campos Ramos G (2021) The healing myocardium mobilizes a distinct B-cell subset through a CXCL13-CXCR5-dependent mechanism. Cardiovasc Res. https:\/\/doi.org\/10.1093\/cvr\/cvab181","journal-title":"Cardiovasc Res"},{"key":"1140_CR53","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/s41569-024-01114-x","volume":"22","author":"G Heusch","year":"2025","unstructured":"Heusch G, Kleinbongard P (2025) The spleen in ischaemic heart disease. Nat Rev Cardiol 22:497\u2013509. https:\/\/doi.org\/10.1038\/s41569-024-01114-x","journal-title":"Nat Rev Cardiol"},{"key":"1140_CR54","doi-asserted-by":"publisher","first-page":"3007","DOI":"10.1002\/eji.201040545","volume":"40","author":"NE Holodick","year":"2010","unstructured":"Holodick NE, Tumang JR, Rothstein TL (2010) Immunoglobulin secretion by B1 cells: differential intensity and IRF4-dependence of spontaneous IgM secretion by peritoneal and splenic B1 cells. Eur J Immunol 40:3007\u20133016. https:\/\/doi.org\/10.1002\/eji.201040545","journal-title":"Eur J Immunol"},{"key":"1140_CR55","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1535703","volume":"16","author":"P Hu","year":"2025","unstructured":"Hu P, Liu W, Huang J, Su Y, Jiang H, Wu Q, Tao J, Liang S, Lin J, Zheng J (2025) Navarixin alleviates cardiac remodeling after myocardial infarction by decreasing neutrophil infiltration and the inflammatory response. Front Pharmacol 16:1535703. https:\/\/doi.org\/10.3389\/fphar.2025.1535703","journal-title":"Front Pharmacol"},{"key":"1140_CR56","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.167201","volume":"9","author":"F Huang","year":"2024","unstructured":"Huang F, Zhang J, Zhou H, Qu T, Wang Y, Jiang K, Liu Y, Xu Y, Chen M, Chen L (2024) B cell subsets contribute to myocardial protection by inducing neutrophil apoptosis after ischemia and reperfusion. JCI Insight 9:e167201. https:\/\/doi.org\/10.1172\/jci.insight.167201","journal-title":"JCI Insight"},{"key":"1140_CR57","doi-asserted-by":"publisher","first-page":"2944","DOI":"10.1111\/febs.14466","volume":"285","author":"CE Hughes","year":"2018","unstructured":"Hughes CE, Nibbs RJB (2018) A guide to chemokines and their receptors. FEBS J 285:2944\u20132971. https:\/\/doi.org\/10.1111\/febs.14466","journal-title":"FEBS J"},{"issue":"3","key":"1140_CR58","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1002\/eji.201343907","volume":"44","author":"ML Humpert","year":"2014","unstructured":"Humpert ML, Pinto D, Jarrossay D, Thelen M (2014) CXCR 7 influences the migration of B cells during maturation. Eur J Immunol 44(3):694\u2013705","journal-title":"Eur J Immunol"},{"key":"1140_CR59","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1158\/1078-0432.CCR-09-2697","volume":"16","author":"T Ishii","year":"2010","unstructured":"Ishii T, Ishida T, Utsunomiya A, Inagaki A, Yano H, Komatsu H, Iida S, Imada K, Uchiyama T, Akinaga S, Shitara K, Ueda R (2010) Defucosylated humanized anti-CCR4 monoclonal antibody KW-0761 as a novel immunotherapeutic agent for adult T-cell leukemia\/lymphoma. Clin Cancer Res 16:1520\u20131531. https:\/\/doi.org\/10.1158\/1078-0432.CCR-09-2697","journal-title":"Clin Cancer Res"},{"key":"1140_CR60","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s00395-024-01033-5","volume":"119","author":"I Jansen","year":"2024","unstructured":"Jansen I, Cahalane R, Hengst R, Akyildiz A, Farrell E, Gijsen F, Aikawa E, van der Heiden K, Wissing T (2024) The interplay of collagen, macrophages, and microcalcification in atherosclerotic plaque cap rupture mechanics. Basic Res Cardiol 119:193\u2013213. https:\/\/doi.org\/10.1007\/s00395-024-01033-5","journal-title":"Basic Res Cardiol"},{"key":"1140_CR61","doi-asserted-by":"publisher","DOI":"10.1007\/s00395-021-00886-4","volume":"116","author":"J Jiao","year":"2021","unstructured":"Jiao J, He S, Wang Y, Lu Y, Gu M, Li D, Tang T, Nie S, Zhang M, Lv B, Li J, Xia N, Cheng X (2021) Regulatory B cells improve ventricular remodeling after myocardial infarction by modulating monocyte migration. Basic Res Cardiol 116:46. https:\/\/doi.org\/10.1007\/s00395-021-00886-4","journal-title":"Basic Res Cardiol"},{"key":"1140_CR62","doi-asserted-by":"publisher","first-page":"5173","DOI":"10.1182\/blood-2009-07-235960","volume":"114","author":"M Jourdan","year":"2009","unstructured":"Jourdan M, Caraux A, De Vos J, Fiol G, Larroque M, Cognot C, Bret C, Duperray C, Hose D, Klein B (2009) An in vitro model of differentiation of memory B cells into plasmablasts and plasma cells including detailed phenotypic and molecular characterization. Blood 114:5173\u20135181. https:\/\/doi.org\/10.1182\/blood-2009-07-235960","journal-title":"Blood"},{"key":"1140_CR63","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1084\/jem.20171067","volume":"215","author":"EE Kara","year":"2018","unstructured":"Kara EE, Bastow CR, McKenzie DR, Gregor CE, Fenix KA, Babb R, Norton TS, Zotos D, Rodda LB, Hermes JR, Bourne K, Gilchrist DS, Nibbs RJ, Alsharifi M, Vinuesa CG, Tarlinton DM, Brink R, Hill GR, Cyster JG, Comerford I, McColl SR (2018) Atypical chemokine receptor 4 shapes activated B cell fate. J Exp Med 215:801\u2013813. https:\/\/doi.org\/10.1084\/jem.20171067","journal-title":"J Exp Med"},{"key":"1140_CR64","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1038\/gt.2011.126","volume":"19","author":"T Kiyota","year":"2012","unstructured":"Kiyota T, Ingraham KL, Swan RJ, Jacobsen MT, Andrews SJ, Ikezu T (2012) AAV serotype 2\/1-mediated gene delivery of anti-inflammatory interleukin-10 enhances neurogenesis and cognitive function in APP+PS1 mice. Gene Ther 19:724\u2013733. https:\/\/doi.org\/10.1038\/gt.2011.126","journal-title":"Gene Ther"},{"key":"1140_CR65","doi-asserted-by":"publisher","first-page":"5273","DOI":"10.4049\/jimmunol.1302209","volume":"192","author":"C Klasen","year":"2014","unstructured":"Klasen C, Ohl K, Sternkopf M, Shachar I, Schmitz C, Heussen N, Hobeika E, Levit-Zerdoun E, Tenbrock K, Reth M, Bernhagen J, El Bounkari O (2014) MIF promotes B cell chemotaxis through the receptors CXCR4 and CD74 and ZAP-70 signaling. J Immunol 192:5273\u20135284. https:\/\/doi.org\/10.4049\/jimmunol.1302209","journal-title":"J Immunol"},{"key":"1140_CR66","first-page":"121","volume":"61","author":"A Kumar","year":"2015","unstructured":"Kumar A, Saba JD (2015) Regulation of immune cell migration by sphingosine-1-phosphate. Cell Mol Biol (OMICS) 61:121","journal-title":"Cell Mol Biol (OMICS)"},{"key":"1140_CR67","doi-asserted-by":"publisher","first-page":"4410","DOI":"10.4049\/jimmunol.1000033","volume":"185","author":"T Kyaw","year":"2010","unstructured":"Kyaw T, Tay C, Khan A, Dumouchel V, Cao A, To K, Kehry M, Dunn R, Agrotis A, Tipping P, Bobik A, Toh B-H (2010) Conventional B2 B cell depletion ameliorates whereas its adoptive transfer aggravates atherosclerosis. J Immunol 185:4410\u20134419. https:\/\/doi.org\/10.4049\/jimmunol.1000033","journal-title":"J Immunol"},{"key":"1140_CR68","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1161\/CIRCRESAHA.111.248542","volume":"109","author":"T Kyaw","year":"2011","unstructured":"Kyaw T, Tay C, Krishnamurthi S, Kanellakis P, Agrotis A, Tipping P, Bobik A, Toh B-H (2011) B1a B lymphocytes are atheroprotective by secreting natural IgM that increases IgM deposits and reduces necrotic cores in atherosclerotic lesions. Circ Res 109:830\u2013840. https:\/\/doi.org\/10.1161\/CIRCRESAHA.111.248542","journal-title":"Circ Res"},{"key":"1140_CR69","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1161\/CIRCULATIONAHA.109.868158","volume":"120","author":"MJ Lewis","year":"2009","unstructured":"Lewis MJ, Malik TH, Ehrenstein MR, Boyle JJ, Botto M, Haskard DO (2009) Immunoglobulin M is required for protection against atherosclerosis in low-density lipoprotein receptor-deficient mice. Circulation 120:417\u2013426. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.109.868158","journal-title":"Circulation"},{"key":"1140_CR70","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.765768","volume":"12","author":"X Lu","year":"2022","unstructured":"Lu X, Wang Z, Ye D, Feng Y, Liu M, Xu Y, Wang M, Zhang J, Liu J, Zhao M, Xu S, Ye J, Wan J (2022) The role of CXC chemokines in cardiovascular diseases. Front Pharmacol 12:765768. https:\/\/doi.org\/10.3389\/fphar.2021.765768","journal-title":"Front Pharmacol"},{"key":"1140_CR71","doi-asserted-by":"publisher","first-page":"9448","DOI":"10.1073\/pnas.95.16.9448","volume":"95","author":"Q Ma","year":"1998","unstructured":"Ma Q, Jones D, Borghesani PR, Segal RA, Nagasawa T, Kishimoto T, Bronson RT, Springer TA (1998) Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice. Proc Natl Acad Sci U S A 95:9448\u20139453. https:\/\/doi.org\/10.1073\/pnas.95.16.9448","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1140_CR72","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1046\/j.1365-2567.2002.01478.x","volume":"107","author":"K Matin","year":"2002","unstructured":"Matin K, Salam MA, Akhter J, Hanada N, Senpuku H (2002) Role of stromal-cell derived factor-1 in the development of autoimmune diseases in non-obese diabetic mice. Immunology 107:222\u2013232. https:\/\/doi.org\/10.1046\/j.1365-2567.2002.01478.x","journal-title":"Immunology"},{"key":"1140_CR73","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/nri1669","volume":"5","author":"RE Mebius","year":"2005","unstructured":"Mebius RE, Kraal G (2005) Structure and function of the spleen. Nat Rev Immunol 5:606\u2013616. https:\/\/doi.org\/10.1038\/nri1669","journal-title":"Nat Rev Immunol"},{"key":"1140_CR74","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1160\/TH17-04-0271","volume":"118","author":"S Merckelbach","year":"2018","unstructured":"Merckelbach S, Van Der Vorst E, Kallmayer M, Rischpler C, Burgkart R, D\u00f6ring Y, De Borst G-J, Schwaiger M, Eckstein H-H, Weber C, Pelisek J (2018) Expression and cellular localization of CXCR4 and CXCL12 in human carotid atherosclerotic plaques. Thromb Haemost 118:195\u2013206. https:\/\/doi.org\/10.1160\/TH17-04-0271","journal-title":"Thromb Haemost"},{"key":"1140_CR75","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1742-2094-11-22","volume":"11","author":"NL Monson","year":"2014","unstructured":"Monson NL, Ortega SB, Ireland SJ, Meeuwissen AJ, Chen D, Plautz EJ, Shubel E, Kong X, Li MK, Freriks LH, Stowe AM (2014) Repetitive hypoxic preconditioning induces an immunosuppressed B cell phenotype during endogenous protection from stroke. J Neuroinflammation 11:22. https:\/\/doi.org\/10.1186\/1742-2094-11-22","journal-title":"J Neuroinflammation"},{"key":"1140_CR76","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.immuni.2011.11.017","volume":"36","author":"E Montecino-Rodriguez","year":"2012","unstructured":"Montecino-Rodriguez E, Dorshkind K (2012) B-1 b cell development in the fetus and adult. Immunity 36:13\u201321. https:\/\/doi.org\/10.1016\/j.immuni.2011.11.017","journal-title":"Immunity"},{"key":"1140_CR77","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1080\/07853890.2021.1974084","volume":"53","author":"HAS Murad","year":"2021","unstructured":"Murad HAS, Rafeeq MM, Alqurashi TMA (2021) Role and implications of the CXCL12\/CXCR4\/CXCR7 axis in atherosclerosis: still a debate. Ann Med 53:1598\u20131612. https:\/\/doi.org\/10.1080\/07853890.2021.1974084","journal-title":"Ann Med"},{"key":"1140_CR78","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/sji.12336","volume":"82","author":"KP Nera","year":"2015","unstructured":"Nera KP, Kyl\u00e4niemi MK, Lassila O (2015) Regulation of B cell to plasma cell transition within the follicular B cell response. Scand J Immunol 82:225\u2013234. https:\/\/doi.org\/10.1111\/sji.12336","journal-title":"Scand J Immunol"},{"key":"1140_CR79","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1084\/jem.20041185","volume":"200","author":"Y Nie","year":"2004","unstructured":"Nie Y, Waite J, Brewer F, Sunshine M-J, Littman DR, Zou Y-R (2004) The role of CXCR4 in maintaining peripheral B cell compartments and humoral immunity. J Exp Med 200:1145\u20131156. https:\/\/doi.org\/10.1084\/jem.20041185","journal-title":"J Exp Med"},{"key":"1140_CR80","doi-asserted-by":"publisher","first-page":"2598","DOI":"10.1161\/ATVBAHA.120.314607","volume":"40","author":"M Nus","year":"2020","unstructured":"Nus M, Basatemur G, Galan M, Cros-Bruns\u00f3 L, Zhao TX, Masters L, Harrison J, Figg N, Tsiantoulas D, Geissmann F, Binder CJ, Sage AP, Mallat Z (2020) NR4A1 deletion in marginal zone B cells exacerbates atherosclerosis in mice\u2014brief report. ATVB 40:2598\u20132604. https:\/\/doi.org\/10.1161\/ATVBAHA.120.314607","journal-title":"ATVB"},{"key":"1140_CR81","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/nm.4315","volume":"23","author":"M Nus","year":"2017","unstructured":"Nus M, Sage AP, Lu Y, Masters L, Lam BYH, Newland S, Weller S, Tsiantoulas D, Raffort J, Marcus D, Finigan A, Kitt L, Figg N, Schirmbeck R, Kneilling M, Yeo GSH, Binder CJ, De La Pompa JL, Mallat Z (2017) Marginal zone B cells control the response of follicular helper T cells to a high-cholesterol diet. Nat Med 23:601\u2013610. https:\/\/doi.org\/10.1038\/nm.4315","journal-title":"Nat Med"},{"key":"1140_CR82","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1084\/jem.20020201","volume":"196","author":"T Okada","year":"2002","unstructured":"Okada T, Ngo VN, Ekland EH, F\u00f6rster R, Lipp M, Littman DR, Cyster JG (2002) Chemokine requirements for B cell entry to lymph nodes and Peyer\u2019s patches. J Exp Med 196:65\u201375. https:\/\/doi.org\/10.1084\/jem.20020201","journal-title":"J Exp Med"},{"key":"1140_CR83","doi-asserted-by":"publisher","first-page":"4983","DOI":"10.1073\/pnas.1913292117","volume":"117","author":"SB Ortega","year":"2020","unstructured":"Ortega SB, Torres VO, Latchney SE, Whoolery CW, Noorbhai IZ, Poinsatte K, Selvaraj UM, Benson MA, Meeuwissen AJM, Plautz EJ, Kong X, Ramirez DM, Ajay AD, Meeks JP, Goldberg MP, Monson NL, Eisch AJ, Stowe AM (2020) B cells migrate into remote brain areas and support neurogenesis and functional recovery after focal stroke in mice. Proc Natl Acad Sci U S A 117:4983\u20134993. https:\/\/doi.org\/10.1073\/pnas.1913292117","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1140_CR84","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.2174\/156802610791561237","volume":"10","author":"R P Gladue","year":"2010","unstructured":"P Gladue R, F Brown M, H Zwillich S (2010) CCR1 antagonists: what have we learned from clinical trials. CTMC 10:1268\u20131277. https:\/\/doi.org\/10.2174\/156802610791561237","journal-title":"CTMC"},{"key":"1140_CR85","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/9065181","volume":"2018","author":"L Pan","year":"2018","unstructured":"Pan L, Lv J, Zhang Z, Zhang Y (2018) Adaptation and constraint in the atypical chemokine receptor family in mammals. BioMed Res Int 2018:1\u20139. https:\/\/doi.org\/10.1155\/2018\/9065181","journal-title":"BioMed Res Int"},{"key":"1140_CR86","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1038\/s44161-023-00356-1","volume":"2","author":"T Pattarabanjird","year":"2023","unstructured":"Pattarabanjird T, Nguyen AT, McSkimming C, Dinh HQ, Marshall MA, Ghosheh Y, Gulati R, Durant C, Vallejo J, Saigusa R, Drago F, Guy TV, Premo K, Taylor AM, Paul S, Kundu B, Berr S, Gonen A, Tsimikas S, Miller Y, Pillai S, Ley K, Hedrick CC, McNamara CA (2023) Human circulating CD24hi marginal zone B cells produce IgM targeting atherogenic antigens and confer protection from vascular disease. Nat Cardiovasc Res 2:1003\u20131014. https:\/\/doi.org\/10.1038\/s44161-023-00356-1","journal-title":"Nat Cardiovasc Res"},{"key":"1140_CR87","doi-asserted-by":"publisher","first-page":"2771","DOI":"10.1161\/ATVBAHA.113.302571","volume":"33","author":"HM Perry","year":"2013","unstructured":"Perry HM, Oldham SN, Fahl SP, Que X, Gonen A, Harmon DB, Tsimikas S, Witztum JL, Bender TP, McNamara CA (2013) Helix-loop-helix factor inhibitor of differentiation 3 regulates interleukin-5 expression and B-1a B cell proliferation. ATVB 33:2771\u20132779. https:\/\/doi.org\/10.1161\/ATVBAHA.113.302571","journal-title":"ATVB"},{"key":"1140_CR88","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.cyto.2018.02.024","volume":"109","author":"KE Quinn","year":"2018","unstructured":"Quinn KE, Mackie DI, Caron KM (2018) Emerging roles of atypical chemokine receptor 3 (ACKR3) in normal development and physiology. Cytokine 109:17\u201323. https:\/\/doi.org\/10.1016\/j.cyto.2018.02.024","journal-title":"Cytokine"},{"key":"1140_CR89","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.107951","volume":"32","author":"E Radice","year":"2020","unstructured":"Radice E, Ameti R, Melgrati S, Foglierini M, Antonello P, Stahl RAK, Thelen S, Jarrossay D, Thelen M (2020) Marginal zone formation requires ACKR3 expression on B cells. Cell Rep 32:107951. https:\/\/doi.org\/10.1016\/j.celrep.2020.107951","journal-title":"Cell Rep"},{"key":"1140_CR90","doi-asserted-by":"publisher","first-page":"e28","DOI":"10.1161\/CIRCRESAHA.117.306044","volume":"117","author":"SM Rosenfeld","year":"2015","unstructured":"Rosenfeld SM, Perry HM, Gonen A, Prohaska TA, Srikakulapu P, Grewal S, Das D, McSkimming C, Taylor AM, Tsimikas S, Bender TP, Witztum JL, McNamara CA (2015) B-1b cells secrete atheroprotective IgM and attenuate atherosclerosis. Circ Res 117:e28\u2013e39. https:\/\/doi.org\/10.1161\/CIRCRESAHA.117.306044","journal-title":"Circ Res"},{"key":"1140_CR91","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1038\/nm.3680","volume":"20","author":"EC Rosser","year":"2014","unstructured":"Rosser EC, Oleinika K, Tonon S, Doyle R, Bosma A, Carter NA, Harris KA, Jones SA, Klein N, Mauri C (2014) Regulatory b cells are induced by gut microbiota\u2013driven interleukin-1\u03b2 and interleukin-6 production. Nat Med 20:1334\u20131339. https:\/\/doi.org\/10.1038\/nm.3680","journal-title":"Nat Med"},{"key":"1140_CR92","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1161\/ATVBAHA.115.305568","volume":"35","author":"AP Sage","year":"2015","unstructured":"Sage AP, Nus M, Baker LL, Finigan AJ, Masters LM, Mallat Z (2015) Regulatory B cell-specific interleukin-10 is dispensable for atherosclerosis development in mice. ATVB 35:1770\u20131773. https:\/\/doi.org\/10.1161\/ATVBAHA.115.305568","journal-title":"ATVB"},{"key":"1140_CR93","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/s41569-018-0106-9","volume":"16","author":"AP Sage","year":"2019","unstructured":"Sage AP, Tsiantoulas D, Binder CJ, Mallat Z (2019) The role of B cells in atherosclerosis. Nat Rev Cardiol 16:180\u2013196. https:\/\/doi.org\/10.1038\/s41569-018-0106-9","journal-title":"Nat Rev Cardiol"},{"key":"1140_CR94","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.591386","volume":"11","author":"S Santagata","year":"2021","unstructured":"Santagata S, Ieran\u00f2 C, Trotta AM, Capiluongo A, Auletta F, Guardascione G, Scala S (2021) CXCR4 and CXCR7 signaling pathways: a focus on the cross-talk between cancer cells and tumor microenvironment. Front Oncol 11:591386. https:\/\/doi.org\/10.3389\/fonc.2021.591386","journal-title":"Front Oncol"},{"key":"1140_CR95","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/ni1571","volume":"9","author":"A Sapoznikov","year":"2008","unstructured":"Sapoznikov A, Pewzner-Jung Y, Kalchenko V, Krauthgamer R, Shachar I, Jung S (2008) Perivascular clusters of dendritic cells provide critical survival signals to B cells in bone marrow niches. Nat Immunol 9:388\u2013395. https:\/\/doi.org\/10.1038\/ni1571","journal-title":"Nat Immunol"},{"key":"1140_CR96","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.1084\/jem.20161122","volume":"214","author":"HP Savage","year":"2017","unstructured":"Savage HP, Yenson VM, Sawhney SS, Mousseau BJ, Lund FE, Baumgarth N (2017) Blimp-1\u2013dependent and \u2013independent natural antibody production by B-1 and B-1\u2013derived plasma cells. J Exp Med 214:2777\u20132794. https:\/\/doi.org\/10.1084\/jem.20161122","journal-title":"J Exp Med"},{"issue":"8","key":"1140_CR97","doi-asserted-by":"publisher","first-page":"4428","DOI":"10.1096\/fj.201800058R","volume":"32","author":"C Schmitz","year":"2018","unstructured":"Schmitz C, Noels H, El Bounkari O, Straussfeld E, Megens RT, Sternkopf M, Alampour-Rajabi S, Krammer C, Tilstam PV, Gerdes N, B\u00fcrger C (2018) Mif-deficiency favors an atheroprotective autoantibody phenotype in atherosclerosis. FASEB J 32(8):4428\u20134443. https:\/\/doi.org\/10.1096\/fj.201800058R","journal-title":"FASEB J"},{"key":"1140_CR98","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-017-0890-x","volume":"14","author":"MK Schuhmann","year":"2017","unstructured":"Schuhmann MK, Langhauser F, Kraft P, Kleinschnitz C (2017) B cells do not have a major pathophysiologic role in acute ischemic stroke in mice. J Neuroinflammation 14:112. https:\/\/doi.org\/10.1186\/s12974-017-0890-x","journal-title":"J Neuroinflammation"},{"key":"1140_CR99","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/cei\/uxae031","volume":"217","author":"K Shah","year":"2024","unstructured":"Shah K, Leandro M, Cragg M, Kollert F, Schuler F, Klein C, Reddy V (2024) Disrupting B and T-cell collaboration in autoimmune disease: T-cell engagers versus CAR T-cell therapy? Clin Exp Immunol 217:15\u201330. https:\/\/doi.org\/10.1093\/cei\/uxae031","journal-title":"Clin Exp Immunol"},{"key":"1140_CR100","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/80886","volume":"1","author":"A Shibuya","year":"2000","unstructured":"Shibuya A, Sakamoto N, Shimizu Y, Shibuya K, Osawa M, Hiroyama T, Eyre HJ, Sutherland GR, Endo Y, Fujita T, Miyabayashi T, Sakano S, Tsuji T, Nakayama E, Phillips JH, Lanier LL, Nakauchi H (2000) Fc\u03b1\/\u03bc receptor mediates endocytosis of IgM-coated microbes. Nat Immunol 1:441\u2013446. https:\/\/doi.org\/10.1038\/80886","journal-title":"Nat Immunol"},{"key":"1140_CR101","doi-asserted-by":"publisher","first-page":"14759","DOI":"10.1073\/pnas.0702229104","volume":"104","author":"F Sierro","year":"2007","unstructured":"Sierro F, Biben C, Mart\u00ednez-Mu\u00f1oz L, Mellado M, Ransohoff RM, Li M, Woehl B, Leung H, Groom J, Batten M, Harvey RP, Mart\u00ednez-A C, Mackay CR, Mackay F (2007) Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12\/SDF-1 receptor, CXCR7. Proc Natl Acad Sci U S A 104:14759\u201314764. https:\/\/doi.org\/10.1073\/pnas.0702229104","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1140_CR102","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.636013","volume":"12","author":"P Srikakulapu","year":"2021","unstructured":"Srikakulapu P, Upadhye A, Drago F, Perry HM, Bontha SV, McSkimming C, Marshall MA, Taylor AM, McNamara CA (2021) Chemokine receptor-6 promotes B-1 cell trafficking to perivascular adipose tissue, local IgM production and atheroprotection. Front Immunol 12:636013. https:\/\/doi.org\/10.3389\/fimmu.2021.636013","journal-title":"Front Immunol"},{"key":"1140_CR103","doi-asserted-by":"publisher","first-page":"719","DOI":"10.3389\/fphys.2017.00719","volume":"8","author":"P Srikakulapu","year":"2017","unstructured":"Srikakulapu P, Upadhye A, Rosenfeld SM, Marshall MA, McSkimming C, Hickman AW, Mauldin IS, Ailawadi G, Lopes MBS, Taylor AM, McNamara CA (2017) Perivascular adipose tissue harbors atheroprotective IgM-producing B cells. Front Physiol 8:719. https:\/\/doi.org\/10.3389\/fphys.2017.00719","journal-title":"Front Physiol"},{"key":"1140_CR104","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00395-024-01045-1","volume":"119","author":"L Strohm","year":"2024","unstructured":"Strohm L, Daiber A, Ubbens H, Krishnankutty R, Oelze M, Kuntic M, Hahad O, Klein V, Hoefer IE, von Kriegsheim A, Kleinert H, Atzler D, Lurz P, Weber C, Wild PS, Munzel T, Knosalla C, Lutgens E, Daub S (2024) Role of inflammatory signaling pathways involving the CD40-CD40L-TRAF cascade in diabetes and hypertension-insights from animal and human studies. Basic Res Cardiol 119:1\u201318. https:\/\/doi.org\/10.1007\/s00395-024-01045-1","journal-title":"Basic Res Cardiol"},{"key":"1140_CR105","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1136\/annrheumdis-2011-201605","volume":"72","author":"PP Tak","year":"2013","unstructured":"Tak PP, Balanescu A, Tseluyko V, Bojin S, Drescher E, Dairaghi D, Miao S, Marchesin V, Jaen J, Schall TJ, Bekker P (2013) Chemokine receptor CCR1 antagonist CCX354-C treatment for rheumatoid arthritis: CARAT-2, a randomised, placebo controlled clinical trial. Ann Rheum Dis 72:337\u2013344. https:\/\/doi.org\/10.1136\/annrheumdis-2011-201605","journal-title":"Ann Rheum Dis"},{"key":"1140_CR106","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.cjca.2021.02.009","volume":"37","author":"KK Teo","year":"2021","unstructured":"Teo KK, Rafiq T (2021) Cardiovascular risk factors and prevention: a perspective from developing countries. Can J Cardiol 37:733\u2013743. https:\/\/doi.org\/10.1016\/j.cjca.2021.02.009","journal-title":"Can J Cardiol"},{"key":"1140_CR107","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.immuni.2004.05.001","volume":"20","author":"K Tokoyoda","year":"2004","unstructured":"Tokoyoda K, Egawa T, Sugiyama T, Choi B-I, Nagasawa T (2004) Cellular niches controlling B lymphocyte behavior within bone marrow during development. Immunity 20:707\u2013718. https:\/\/doi.org\/10.1016\/j.immuni.2004.05.001","journal-title":"Immunity"},{"key":"1140_CR108","doi-asserted-by":"publisher","first-page":"e55","DOI":"10.1161\/CIRCRESAHA.119.315786","volume":"125","author":"A Upadhye","year":"2019","unstructured":"Upadhye A, Srikakulapu P, Gonen A, Hendrikx S, Perry HM, Nguyen A, McSkimming C, Marshall MA, Garmey JC, Taylor AM, Bender TP, Tsimikas S, Holodick NE, Rothstein TL, Witztum JL, McNamara CA (2019) Diversification and CXCR4-dependent establishment of the bone marrow B-1a cell pool governs atheroprotective IgM production linked to human coronary atherosclerosis. Circ Res 125:e55\u2013e70. https:\/\/doi.org\/10.1161\/CIRCRESAHA.119.315786","journal-title":"Circ Res"},{"key":"1140_CR109","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1182\/blood-2011-03-343608","volume":"119","author":"H Wang","year":"2012","unstructured":"Wang H, Beaty N, Chen S, Qi C-F, Masiuk M, Shin D-M, Morse HC (2012) The CXCR7 chemokine receptor promotes B-cell retention in the splenic marginal zone and serves as a sink for CXCL12. Blood 119:465\u2013468. https:\/\/doi.org\/10.1182\/blood-2011-03-343608","journal-title":"Blood"},{"key":"1140_CR110","doi-asserted-by":"publisher","DOI":"10.1007\/978-981-15-3532-1","author":"J-Y Wang","year":"2020","unstructured":"Wang J-Y (2020) B cells in immunity and tolerance. Adv Exp Med Biol. https:\/\/doi.org\/10.1007\/978-981-15-3532-1","journal-title":"Adv Exp Med Biol"},{"key":"1140_CR111","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.3389\/fimmu.2019.02031","volume":"10","author":"X Wang","year":"2019","unstructured":"Wang X, Iyer A, Lyons AB, K\u00f6rner H, Wei W (2019) Emerging roles for G-protein coupled receptors in development and activation of macrophages. Front Immunol 10:2031. https:\/\/doi.org\/10.3389\/fimmu.2019.02031","journal-title":"Front Immunol"},{"key":"1140_CR112","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1161\/CIRCRESAHA.118.313591","volume":"124","author":"D Wolf","year":"2019","unstructured":"Wolf D, Ley K (2019) Immunity and inflammation in atherosclerosis. Circ Res 124:315\u2013327. https:\/\/doi.org\/10.1161\/CIRCRESAHA.118.313591","journal-title":"Circ Res"},{"key":"1140_CR113","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1097\/MOH.0000000000000476","volume":"26","author":"X Zhang","year":"2019","unstructured":"Zhang X, Guo R, Kambara H, Ma F, Luo HR (2019) The role of CXCR2 in acute inflammatory responses and its antagonists as anti-inflammatory therapeutics. Curr Opin Hematol 26:28\u201333. https:\/\/doi.org\/10.1097\/MOH.0000000000000476","journal-title":"Curr Opin Hematol"},{"key":"1140_CR114","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1093\/cvr\/cvab113","volume":"118","author":"TX Zhao","year":"2022","unstructured":"Zhao TX, Aetesam-Ur-Rahman M, Sage AP, Victor S, Kurian R, Fielding S, Ait-Oufella H, Chiu YD, Binder CJ, McKie M, Hoole SP, Mallat Z (2022) Rituximab in patients with acute ST-elevation myocardial infarction: an experimental medicine safety study. Cardiovasc Res 118:872\u2013882. https:\/\/doi.org\/10.1093\/cvr\/cvab113","journal-title":"Cardiovasc Res"},{"key":"1140_CR115","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1038\/nm.3284","volume":"19","author":"Y Zouggari","year":"2013","unstructured":"Zouggari Y, Ait-Oufella H, Bonnin P, Simon T, Sage AP, Gu\u00e9rin C, Vilar J, Caligiuri G, Tsiantoulas D, Laurans L, Dumeau E, Kotti S, Bruneval P, Charo IF, Binder CJ, Danchin N, Tedgui A, Tedder TF, Silvestre JS, Mallat Z (2013) B lymphocytes trigger monocyte mobilization and impair heart function after acute myocardial infarction. Nat Med 19:1273\u20131280. https:\/\/doi.org\/10.1038\/nm.3284","journal-title":"Nat Med"}],"container-title":["Basic Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00395-025-01140-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00395-025-01140-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00395-025-01140-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T09:45:07Z","timestamp":1764927907000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00395-025-01140-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,23]]},"references-count":115,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1140"],"URL":"https:\/\/doi.org\/10.1007\/s00395-025-01140-x","relation":{},"ISSN":["1435-1803"],"issn-type":[{"value":"1435-1803","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,23]]},"assertion":[{"value":"20 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}